The outcome of my PhD is the development of a new invention for studying leukaemia. The method, called immuno-flowFISH, enables many thousand cells to be analysed to detect abnormal chromosomes. This invention is a world-first: it is automated, is more precise as only leukaemia cells are analysed and is 1,000-times more sensitive than established tests. Once I established the test, I evaluated its performance on chronic lymphocytic leukaemia, the commonest leukaemia in the western world. This confirmed its capability as a diagnostic test. The invention has been patented and won the ANSTO 2018 Eureka Prize for Innovative use of Technology.